Showing results (2231-2240 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|February 18, 1999
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasmsN G Rainov, K Ikeda, N H Qureshi, et al.Human Gene Therapy|February 27, 1999
Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cellsC Serguera, D Bohl, E Rolland, et al.Human Gene Therapy|May 1, 1995
Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase geneJ J Jonsson, D E Habel, R S McIvorHuman Gene Therapy|July 1, 1995
Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapyC A Richards, E A Austin, B E HuberHuman Gene Therapy|July 1, 1995
Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry diseaseY Sugimoto, I Aksentijevich, G J Murray, et al.Human Gene Therapy|August 1, 1995
Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cellsS Teramoto, L G Johnson, W Huang, et al.Human Gene Therapy|August 1, 1995
Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correctionP L Yeyati, V Agmon, C Fillat, et al.Human Gene Therapy|August 1, 1995
Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodentsJ P Katkin, B E Gilbert, C Langston, et al.Human Gene Therapy|April 1, 1995
Immunization by direct DNA inoculation induces rejection of tumor cell challengeB Wang, M Merva, K Dang, et al.Human Gene Therapy|April 1, 1995
Protection of retroviral vector particles in human blood through complement inhibitionR P Rother, S P Squinto, J M Mason, et al.Pageof 414